Clinical Trial Update: Study to Evaluate Clinical Efficacy and Safety of Nuvastatic™ - C5OSEW5050ESA in Diabetic Retinopathy. [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the efficacy and safety of Nuvastatic for diabetic retinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Nuvastatic

Snippet

Sponsor: Natureceuticals Sdn Bhd | Conditions: Diabetic Retinopathy | Phase 1, Phase 2 | Status: COMPLETED